Literature DB >> 3373110

Decreased ceruloplasmin ferroxidase activity in cigarette smokers.

E R Pacht1, W B Davis.   

Abstract

Ceruloplasmin is one of the most important antioxidant proteins in serum. Ceruloplasmin functions as a ferroxidase that oxidizes iron to the Fe3+ state, thereby preventing Fe2+-catalyzed lipid peroxidation and cellular damage. Despite increased antigenic amounts of ceruloplasmin, cigarette smoker serum has previously been shown to exhibit significantly less antioxidant activity than non-smoker serum. We demonstrate that the decreased antioxidant activity of cigarette smoker serum may be explained by a decrease in ceruloplasmin ferroxidase activity. Smokers had a 14% decrease in serum ceruloplasmin ferroxidase activity (units per milliliter) compared with nonsmokers. There was a 24% decrease in ferroxidase activity per milligram of ceruloplasmin in smokers compared with nonsmokers (0.32 +/- 0.009 U/mg vs 0.42 +/- 0.020 U/mg, p less than 0.005). Smoker serum also contained significantly less ceruloplasmin-specific antioxidant activity than nonsmoker serum. These observations may explain the decrement in smoker serum antioxidant activity that could predispose cigarette smokers to increased oxidant injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373110

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Erythrocyte antioxidant system and serum ceruloplasmin levels in welders.

Authors:  R Mongiat; G C Gerli; G F Locatelli; R Fortuna; A Petazzi
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

2.  What do we really know about serum copper-metallothionein?

Authors:  R A DiSilvestro
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

3.  The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.

Authors:  Suzanne M Cloonan; Sharon Mumby; Ian M Adcock; Augustine M K Choi; Kian Fan Chung; Gregory J Quinlan
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.